Affibody molecules are small (58 amino acids) engineered scaffold proteins that can be
selected to bind to a large variety of proteins with a high affinity. Their small size and high …

Molecular imaging is a biomedical research discipline that has quickly emerged to afford the
observation, characterization, monitoring, and quantification of biomarkers and biological …

Cobalt–sarcophagine complexes exhibit high kinetic inertness under various stringent
conditions, but there is limited literature on radiolabeling and in vivo positron emission …

Molecular imaging of the gastrin-releasing peptide receptor (GRPR) could improve patient
management in prostate cancer. This study aimed to produce gallium-66 (T½= 9.5 h) …

The emerging success of [68Ga/177Lu] Ga/Lu-DOTATATE as a theranostic pair has spurred
interest in other isotopes as potential theranostic combinations. Here, we review cobalt-55 …

The high incidence of prostate cancer (PCa) increases the need for progress in its
diagnosis, staging, and precise treatment. The overexpression of tumor-specific receptors for …

Background Patients with advanced metastatic estrogen receptor-positive breast cancer
often develop resistance to standard treatments, leading to uncontrolled progression. Thus …

Recently, several radiometalated peptides have been approved for clinical imaging and/or
therapy (theranostics) of several types of cancer; nonetheless, the primary challenge that …

Detection of biomarkers to diagnose, treat, and predict the efficacy of cancer therapies is a
major clinical challenge. Currently, biomarkers such as PD-L1 are commonly detected from …

Neurotensin receptor 1 (NTS1) is involved in the development and progression of numerous
cancers, which makes it an interesting target for the development of diagnostic and …